CINECA IRIS Institutional Research Information System

VITTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.138
EU - Europa 17.178
AS - Asia 5.296
AF - Africa 531
SA - Sud America 144
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 15
Totale 54.343
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.103
IT - Italia 8.681
CA - Canada 3.006
CN - Cina 2.515
SE - Svezia 2.461
DE - Germania 1.918
BG - Bulgaria 1.170
SG - Singapore 1.114
TR - Turchia 737
GB - Regno Unito 726
UA - Ucraina 438
VN - Vietnam 410
FI - Finlandia 393
AT - Austria 385
CI - Costa d'Avorio 282
FR - Francia 222
IN - India 178
RU - Federazione Russa 160
CH - Svizzera 154
SN - Senegal 144
HK - Hong Kong 137
NL - Olanda 121
BR - Brasile 99
BE - Belgio 92
GR - Grecia 46
JP - Giappone 38
NG - Nigeria 37
AU - Australia 34
IR - Iran 29
RO - Romania 29
PL - Polonia 28
KR - Corea 25
IE - Irlanda 23
LV - Lettonia 21
ES - Italia 20
CZ - Repubblica Ceca 18
MY - Malesia 17
ZA - Sudafrica 16
BJ - Benin 15
MX - Messico 13
EG - Egitto 12
EU - Europa 11
ZM - Zambia 11
EE - Estonia 10
TW - Taiwan 10
CL - Cile 9
DK - Danimarca 9
HU - Ungheria 9
LT - Lituania 9
PY - Paraguay 9
IL - Israele 8
JO - Giordania 8
PK - Pakistan 8
UZ - Uzbekistan 8
AR - Argentina 7
NZ - Nuova Zelanda 7
TH - Thailandia 7
CO - Colombia 6
CR - Costa Rica 6
SA - Arabia Saudita 6
EC - Ecuador 5
HR - Croazia 5
ID - Indonesia 5
PH - Filippine 5
SM - San Marino 5
IQ - Iraq 4
KE - Kenya 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AL - Albania 3
BD - Bangladesh 3
BH - Bahrain 3
BY - Bielorussia 3
CY - Cipro 3
KZ - Kazakistan 3
LY - Libia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AZ - Azerbaigian 2
DZ - Algeria 2
IS - Islanda 2
JM - Giamaica 2
LU - Lussemburgo 2
MT - Malta 2
NO - Norvegia 2
SI - Slovenia 2
SV - El Salvador 2
UY - Uruguay 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CU - Cuba 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
Totale 54.328
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.414
Fairfield 3.271
Ann Arbor 2.473
Houston 2.408
Montreal 2.321
Chandler 2.156
Ashburn 1.844
Santa Clara 1.568
Milan 1.385
Seattle 1.358
Wilmington 1.200
Sofia 1.167
Cambridge 1.057
Beijing 776
New York 702
Singapore 656
Ottawa 629
Princeton 509
Boardman 483
Serra 472
Jacksonville 450
Lawrence 448
Rome 447
Izmir 445
Medford 398
Vienna 355
Nanjing 340
Florence 328
Des Moines 327
Abidjan 282
Istanbul 223
Dearborn 203
Pisa 169
Dong Ket 168
Boulder 159
San Diego 153
Dakar 144
Frankfurt am Main 140
London 138
Naples 134
Falls Church 119
Redwood City 119
Nanchang 117
Bern 116
Bremen 115
Hong Kong 112
Jüchen 100
Ogden 93
Shanghai 93
Lancaster 90
Brussels 83
Palermo 83
Bologna 82
Kunming 79
Shenyang 76
Hebei 74
Bari 72
Turin 71
Dallas 70
Marseille 70
Fuzhou 68
Los Angeles 66
Tianjin 63
Changsha 58
Washington 57
Brescia 56
Detroit 56
Jiaxing 56
Hefei 54
Munich 51
Catania 50
Jinan 49
Düsseldorf 47
Guangzhou 46
Kocaeli 42
Padova 42
Quanzhou 41
Nürnberg 39
Lagos 37
Norwalk 37
Helsinki 36
Hangzhou 35
Phoenix 33
Pune 33
Genoa 32
Ningbo 32
Toronto 30
Chicago 28
Livorno 28
Cagliari 26
Napoli 26
Verona 26
Vicopisano 26
Sacile 23
San Francisco 23
Chengdu 22
Bergamo 21
Lanzhou 21
Zhengzhou 21
Torino 20
Totale 38.691
Salva come PNG Salva come JPEG
Nome #
Tiroidite cronica autoimmune 8.388
Ontogenetic development of pancreatic thyrotropin-releasing hormone in human foetuses and in infants. 317
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 197
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 192
Leonardo da Vinci "Design of Lady with Graves' disease" (1452-1519) 188
Natural history of graves’ orbitopathy after treatment 179
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 178
Artificial neural networks in the outcome prediction of adjustable gastric banding in obese women. 177
Sera of patients with idiopathic myxedema contain IgG which block TSH-stimulated thyroid adenylate cyclase 172
Gozzo diffuso tossico (morbo di Flajani-Basedow-Graves) e tiroidite cronica autoimmune, Inquadramento nosologico e terapia medica 172
uptake of amiodarone by thyroidal and non-thyroidal cell lines 170
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 170
Expression of the microsomal antigen on the surface of continuously cultured rat thyroid cells is modulated by thyrotropin. 169
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 169
V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER 169
Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome 168
A study on the relationship between intraglandular arterial distribution and thyroid lobe shape: implications for biotechnology of a bioartificial thyroid 168
Effects of bariatric surgery on preclinical myocardial alterations in severe obesity 164
Causes and laboratory investigations of thyrotoxicosis 161
null 160
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 160
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 159
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding 157
null 157
Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules 156
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 156
In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity 155
Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules. 155
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 155
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 155
Results of Vardenafil Mediated Power Doppler Ultrasound, Contrast Enhanced Ultrasound and Systematic Random Biopsies to Detect Prostate Cancer 153
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 151
Thyrotropin stimulation of the ADP-ribosyltransferase activity of bovine thyroid membranes. 149
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 149
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 149
Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. 148
Prevalence of thyroid peroxidase, thyroglobulin and thyrotropin receptor antibodies in a long-term follow-up of juvenile Graves disease 148
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 148
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 148
Radioactive iodine (131I) effects on male fertility 147
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 146
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib 146
Thyroid-stimulating antibody mimics thyrotropin in its ability to desensitize the adenosine 3',5'-monophosphate response to acute stimulation in continuously cultured rat thyroid cells (FRT-L5). 145
Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. 145
Interference of serum thyroglobulin in the radioassay for serum antithyroglobulin antibodies. 144
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 144
STUDY OF POTENTIAL INHIBITORS OF THYROID IODIDE UPTAKE BY USING CHO CELLS STABLY EXPRESSING THE HUMAN SODIUM/IODIDE SYMPORTER (hNIS) PROTEIN 143
Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease. 143
Thyroglobulin Antibodies (TgAb) Titer Spontaneously Decrease Until The Negativization Or Stabilization In Most Of Cases Of Papillary Thyroid Microcarcinoma (mPTC) Treated With Total Thyroidectomy But Not Ablated With 131I 143
Molecular interactions at the cell surface: role of glycoconjugates and membrane lipids in receptor recognition processes. 142
Diagnosis of thyroid dysfunction: present and future. 142
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 142
Electric and magnetic fields do not modify the biochemical properties of FRTL-5 cells 142
The expression of platelet serotonin transporter (SERT) in human obesity 142
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 142
Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M.: Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation 141
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 141
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 139
Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women 139
Authors’ Response: Haptoglobin and Body Mass Index 139
Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. 138
Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma 138
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease 137
null 137
Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter 137
Binding of thyroglobulin (Tg) to the low-density lipoprotein receptor-associated protein (RAP) during the biosynthetic pathway prevents premature Tg interactions with sortilin 137
Iodine deficiency from pregnancy to childhood 137
A TSHr-LH/CGr Chimera that Measures Functional TSAb in Graves' Disease. 136
Assessment of nodular goitre 136
Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. 134
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 134
Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. 134
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre 134
Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay. 133
Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. 133
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. 132
Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. 132
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 132
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 129
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 129
The spectrum of thyroid disorders in an iodine deficient community: the Pescopagano survey 128
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. 127
Non-palpable thyroid nodules in a borderline iodine-sufficient area: detection by ultrasonography and follow-up. 127
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves 127
Identification and functional studies of two new dual-oxidase 2 (DUOX2) mutations in a child with congenital hypothyroidism and a eutopic normal-size thyroid gland 127
Interventional bronchoscopy in the treatment of tracheal obstruction secondary to advanced thyroid cancer 127
Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype 127
Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato 127
Percutaneous ethanol injection: what is its role in the management of nodular lesions of endocrine glands? 125
THE LOCATION AND THE REGULATION OF THE TYPE I-IODOTHYRONINE 5'-MONODEIODINASE (TYPE I-MD) IN THE RAT-THYROID - STUDIES USING A SPECIFIC ANTI-TYPE I-MD ANTIBODY 125
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 125
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 125
Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. 124
Thyroid volume in children: role of iodine intake. 124
Metabolic engineering of the iodine content in Arabidopsis. 124
Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions 124
Functioning and non functioning thyroid adenomas involve different molecular pathogenetic mechanisms 124
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 124
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 124
null 124
Totale 22.931
Salva come PNG Salva come JPEG
Categoria #
all - tutte 134.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.651
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.486 0 0 0 0 0 1.037 1.097 774 902 618 844 214
2020/20214.144 420 276 327 208 400 285 244 407 343 383 267 584
2021/20225.814 110 233 135 379 1.192 829 172 261 464 361 238 1.440
2022/20237.877 848 943 578 646 815 912 172 607 1.316 168 638 234
2023/20249.095 734 622 685 438 803 1.003 370 540 240 2.613 393 654
2024/20254.907 293 715 409 1.084 1.494 912 0 0 0 0 0 0
Totale 55.128